Welcome to LookChem.com Sign In|Join Free
  • or
Benzenecarboximidamide, N-(acetyloxy)-4-(aminomethyl)-, monohydrochloride is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

380237-43-4

Post Buying Request

380237-43-4 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

380237-43-4 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 380237-43-4 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 3,8,0,2,3 and 7 respectively; the second part has 2 digits, 4 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 380237-43:
(8*3)+(7*8)+(6*0)+(5*2)+(4*3)+(3*7)+(2*4)+(1*3)=134
134 % 10 = 4
So 380237-43-4 is a valid CAS Registry Number.

380237-43-4SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 19, 2017

Revision Date: Aug 19, 2017

1.Identification

1.1 GHS Product identifier

Product name H-4-Acetyloxamidinobenzylamine.x.HCl

1.2 Other means of identification

Product number -
Other names -

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:380237-43-4 SDS

380237-43-4Downstream Products

380237-43-4Relevant academic research and scientific papers

Base-substituted benzylamine analogs for use as coagulation factor xa inhibitors, the production and use thereof

-

Page/Page column 8, (2008/06/13)

The invention relates to the novel base-substituted benzylamine analogs of general formula (I), wherein A represents P2-P1 with P1=(A) and P2=(B), for use as coagulation factor Xa inhibitors. The invention also relates to the production and use of said analogs in the therapy and prophylaxis of cardiovascular diseases and thromboembolic events.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 380237-43-4